Ambulation with Femoral Central Lines: Safety and Feasibility
Patients with femoral central venous catheters can safely ambulate, and the presence of a femoral line should not automatically restrict patients to bed rest. 1, 2
Key Evidence Supporting Safe Ambulation
The strongest recent research directly addressing this question demonstrates that physical therapy and mobility interventions in ICU patients with femoral catheters are both feasible and safe:
In a prospective study of 101 ICU patients with femoral catheters (venous, arterial, or hemodialysis) who received 253 physical therapy sessions over 210 days, there were zero catheter-related adverse events (0% event rate with 95% upper confidence limit of 2.1% for venous catheters). Activities included standing, walking, sitting, and in-bed exercises 1
A cardiovascular ICU study of 77 patients with 92 femoral catheters (arterial, central venous, and dialysis) documented 210 PT sessions with 630 mobility activities including standing, transfers, and walking with no catheter-related mechanical or thrombotic complications 2
Important Caveats and Context
Guideline Restrictions vs. Real-World Safety
While multiple guidelines recommend avoiding femoral access or limiting its use to bed-bound patients, these recommendations are primarily based on infection risk concerns rather than mechanical complications from ambulation:
The 2001 NKF-K/DOQI guidelines explicitly state that "noncuffed femoral catheters should not be left in place longer than 5 days and should be left in place only in bed-bound patients" 3
The 2011 CDC guidelines recommend avoiding femoral vein use in adult patients to minimize infection risk 4
The 2016 AAGBI guidelines note higher microbial colonization rates in the groin, though tunneling devices may reduce such risks 5
Critical Distinction
The guideline restrictions focus on infection and thrombosis rates compared to other insertion sites, NOT on mechanical complications from patient movement. The research evidence shows that when patients meet criteria for mobility interventions, ambulation does not cause catheter dislodgement, local trauma, or bleeding 1, 2.
Practical Recommendations for Safe Ambulation
When a femoral catheter is already in place and ambulation is being considered:
Ensure adequate catheter securement - The catheter must be properly secured to prevent accidental removal (which occurred in 11.97% of cases in one series, though not specifically during ambulation) 6
Use appropriate catheter length - Femoral catheters should be at least 19 cm long to minimize recirculation 3, and modern tunneled femoral catheters with mid-thigh exit sites average 47.6 cm 6
Consider catheter type and duration:
Monitor for complications - While mechanical complications from ambulation are rare, continue routine monitoring for infection, thrombosis, and catheter function
Apply standard thromboprophylaxis - In one study where 97% of patients received routine thromboprophylaxis, no DVT occurred with short-term femoral catheterization 8
When to Avoid Femoral Lines (But Not Due to Ambulation)
The primary reasons to avoid femoral access are:
- Higher infection rates compared to subclavian sites (though recent data with proper technique shows infection rates as low as 1.3 events/1000 catheter days) 5, 4, 9, 6
- Increased thrombosis risk compared to upper body sites 10
- Preservation of vessels in patients with chronic kidney disease who may need arteriovenous fistulas 10
- Availability of superior alternatives - upper body sites (subclavian or internal jugular) are preferred when feasible 4, 11, 4
Bottom Line
The presence of a femoral central line is not a contraindication to ambulation. The research evidence directly contradicts the older guideline recommendation to restrict femoral catheter patients to bed rest. This restriction appears to have been based on theoretical concerns about mechanical complications that have not materialized in clinical practice. The real concerns with femoral catheters—infection and thrombosis—are related to the anatomical site and duration of use, not patient mobility.